19-48055042-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003706.3(PLA2G4C):c.1265G>A(p.Arg422Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000153 in 1,605,420 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003706.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLA2G4C | NM_003706.3 | c.1265G>A | p.Arg422Gln | missense_variant | 15/17 | ENST00000599921.6 | NP_003697.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLA2G4C | ENST00000599921.6 | c.1265G>A | p.Arg422Gln | missense_variant | 15/17 | 1 | NM_003706.3 | ENSP00000469473.1 |
Frequencies
GnomAD3 genomes AF: 0.000277 AC: 42AN: 151490Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.000161 AC: 39AN: 242766Hom.: 0 AF XY: 0.000160 AC XY: 21AN XY: 131024
GnomAD4 exome AF: 0.000139 AC: 202AN: 1453812Hom.: 0 Cov.: 32 AF XY: 0.000144 AC XY: 104AN XY: 722732
GnomAD4 genome AF: 0.000284 AC: 43AN: 151608Hom.: 0 Cov.: 29 AF XY: 0.000297 AC XY: 22AN XY: 74036
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 04, 2024 | The c.1265G>A (p.R422Q) alteration is located in exon 15 (coding exon 14) of the PLA2G4C gene. This alteration results from a G to A substitution at nucleotide position 1265, causing the arginine (R) at amino acid position 422 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at